Insight into mithramycin disruption of ETS transcription leads to improved understanding of more selective analogs

Structure. 2021 May 6;29(5):401-403. doi: 10.1016/j.str.2021.03.010.

Abstract

Fusion products with the ETS family of transcription factors play critical roles in the etiology of several cancers. In this issue of Structure, Hou et al. (2020) provide insight into allosteric mechanisms by which mithramycin and its analogs perturb protein-DNA interactions in higher-order complexes at a DNA enhancer site.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Comment

MeSH terms

  • Base Sequence
  • DNA
  • Plicamycin* / pharmacology
  • Transcription Factors*

Substances

  • Transcription Factors
  • DNA
  • Plicamycin